High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.

@article{Olsson2005HighdensityLB,
  title={High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.},
  author={Anders G. Olsson and Gregory G. Schwartz and Michael Szarek and W Jordan Sasiela and Michael Ezekowitz and Peter A Ganz and Michael F. Oliver and David K Waters and Andreas Michael Zeiher},
  journal={European heart journal},
  year={2005},
  volume={26 9},
  pages={890-6}
}
AIMS Patients with acute coronary syndrome (ACS) in the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study had diminished cardiovascular events after 16 weeks of treatment of atorvastatin 80 mg daily. We determined whether plasma lipoproteins at baseline and then at 6 weeks after randomization predicted clinical outcome. METHODS AND RESULTS Cox proportional hazards models were constructed to determine relations between lipoproteins and clinical endpoint events… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without STsegment elevation

  • CP Cannon, WS Weintraub, +9 authors E Braunwald
  • N Engl J Med
  • 2001

Similar Papers

Loading similar papers…